Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Change in Receivables: 2023-2025

Historic Change in Receivables for Upstream Bio (UPB) over the last 2 years, with Sep 2025 value amounting to -$254,000.

  • Upstream Bio's Change in Receivables fell 361.86% to -$254,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $76,000, marking a year-over-year decrease of 77.78%. This contributed to the annual value of $515,000 for FY2024, which is 264.01% up from last year.
  • As of Q3 2025, Upstream Bio's Change in Receivables stood at -$254,000, which was down 168.46% from $371,000 recorded in Q2 2025.
  • In the past 5 years, Upstream Bio's Change in Receivables ranged from a high of $640,000 in Q1 2024 and a low of -$254,000 during Q3 2025.
  • For the 3-year period, Upstream Bio's Change in Receivables averaged around $52,250, with its median value being -$20,500 (2024).
  • Over the last 5 years, Upstream Bio's Change in Receivables had its largest YoY gain of 262.72% in 2025, and its largest YoY loss of 361.86% in 2025.
  • Over the past 3 years, Upstream Bio's Change in Receivables (Quarterly) stood at -$167,000 in 2023, then surged by 103.59% to $6,000 in 2024, then plummeted by 361.86% to -$254,000 in 2025.
  • Its Change in Receivables was -$254,000 in Q3 2025, compared to $371,000 in Q2 2025 and -$47,000 in Q1 2025.